Hall Render
JULY 22, 2022
Healthcare Merger and Acquisition Activity Generates $19B in Q2 2022. cancer, cardio lab fraud. NCDHHS releases response plan for 2022 monkeypox outbreak. Davis Regional Medical Center to eliminate most patient services by end of 2022, shift focus to inpatient behavioral health car. HHS orders additional 2.5 NORTH DAKOTA.
Hall Render
FEBRUARY 25, 2022
67 rural hospital CEOs to know | 2022. 67 rural hospital CEOs to know | 2022. Baptist Health one of five Kentucky companies named to Forbes’ America’s Best Large Employers 2022 list. 67 rural hospital CEOs to know | 2022. Whitmer signs bills designed to lower prescription drug prices in Michigan.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hall Render
FEBRUARY 18, 2022
Florida physician convicted of $110M fraud. Bill on prescription drug pricing inspires support from Maine residents, opposition from pharmaceutical industry. billing fraud. Cleveland Clinic’s top 10 medical innovations for 2022. 3 Texas medical labs charged in $300M fraud scheme.
Hall Render
NOVEMBER 11, 2022
Colorado legislators convene to discuss health legislation passed in 2022. in prescription drug pricing case. Assaults against staff surge at Minnesota hospitals: ‘It seems like it’s inevitable’ 2022 CFO of the Year: David Nelsen, Bluestone Physician Services. Express Scripts to shell out $3.2M
Hall Render
FEBRUARY 24, 2023
NATIONAL Addressing Staff Burnout In Healthcare Design Amazon completes $3.9B Staff shortages could spur next public health crisis, Baystate Health CEO warns CommonSpirit, Mass General, Moffitt execs to judge telehealth challenge Brigham and Women’s, AI company get $2.5M grant to improve early cognitive decline detection via EHRs How Mass.
Hall Render
JUNE 2, 2023
operating loss, reversing 2022 gain Patheous Health makes North Carolina acquisition after $15.5M
Drug & Device Law
OCTOBER 10, 2022
The manufacturer sought to cover Medicare patients’ Part D cost-sharing obligations for the drug – which were estimated at approximately $13,000 per year – but the OIG said “no thanks,” and the Second Circuit has affirmed that outcome. 2370 (2022), which the Blog recently wrote about here. 1320a-7b (“AKS”). Pfizer, Inc. Nicholson v.
Expert insights. Personalized for you.
40 
Let's personalize your content